knowledge -WSS

knowledge

author：focus 2025-09-29 20:50:41 - browse：25814

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

WSS

Eliminate the waiting period for sterilization covered by Medicaid

Scientists unlock the key to scar

Clinical trials giant ICON acquires HumanFirst

FogPharma raises $145 million in rare Series E round

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

FDA does about

entertainment

knowledge

hotspot

Medicare details structure of new drug price negotiation program

Abortion pill case raises question: who can sue the FDA?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Supreme Court mifepristone arguments center on docs' right to sue

Trump demands the U.S. pay no more for drugs than other countries … again

Oprah kicked off a national conversation on obesity. Let's have it

State Dept. review finds Biden bears some blame for Afghanistan failures

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Guidelines to prevent youth baseball injuries need more muscle

Vertex Pharmaceuticals may move headquarters in Boston

hotspot

Obesity now affects over 1 billion people worldwide, study finds

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Vertex Pharmaceuticals may move headquarters in Boston

Kenai launches with $82 million for Parkinson’s stem cell therapy

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Merck drug for rare lung condition set for approval in U.S.

hotspot

focus

focus

knowledge